Department of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO, U.S.A.
Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, U.S.A.
Clin Sci (Lond). 2022 Nov 11;136(21):1471-1483. doi: 10.1042/CS20210627.
Type 2 diabetes (T2D) is a global health pandemic with significant humanitarian, economic, and societal implications, particularly for youth and young adults who are experiencing an exponential rise in incident disease. Youth-onset T2D has a more aggressive phenotype than adult-onset T2D, and this translates to important differences in rates of progression of diabetic kidney disease (DKD). We hypothesize that youth-onset DKD due to T2D may exhibit morphometric, metabolic, and molecular characteristics that are distinct from adult-onset T2D and develop secondary to inherent differences in renal energy expenditure and substrate metabolism, resulting in a central metabolic imbalance. Kidney structural changes that are evident at the onset of puberty also serve to exacerbate the organ's baseline high rates of energy expenditure. Additionally, the physiologic state of insulin resistance seen during puberty increases the risk for kidney disease and is exacerbated by both concurrent diabetes and obesity. A metabolic mismatch in renal energetics may represent a novel target for pharmacologic intervention, both for prevention and treatment of DKD. Further investigation into the underlying molecular mechanisms resulting in DKD in youth-onset T2D using metabolomics and RNA sequencing of kidney tissue obtained at biopsy is necessary to expand our understanding of early DKD and potential targets for therapeutic intervention. Furthermore, large-scale clinical trials evaluating the duration of kidney protective effects of pharmacologic interventions that target a metabolic mismatch in kidney energy expenditure are needed to help mitigate the risk of DKD in youth-onset T2D.
2 型糖尿病(T2D)是一种全球性的健康大流行病,对青年人和年轻人有着重大的人道主义、经济和社会影响,因为他们的发病呈指数级上升。与成人发病的 T2D 相比,青年发病的 T2D 具有更具侵袭性的表型,这转化为糖尿病肾病(DKD)进展率的重要差异。我们假设,由于 T2D 引起的青年发病的 DKD 可能表现出形态计量学、代谢和分子特征,与成人发病的 T2D 不同,并且由于肾脏能量消耗和底物代谢的内在差异而发展,导致中心代谢失衡。青春期开始时出现的肾脏结构变化也加剧了器官的高基线能量消耗。此外,青春期期间出现的胰岛素抵抗生理状态增加了患肾脏病的风险,并且糖尿病和肥胖症都会使其恶化。肾脏能量学中的代谢不匹配可能代表一种新的药物干预靶点,无论是预防还是治疗 DKD。通过对活检获得的肾脏组织进行代谢组学和 RNA 测序,进一步研究导致青年发病的 T2D 中 DKD 的潜在分子机制,对于扩展我们对早期 DKD 的理解和治疗干预的潜在靶点非常必要。此外,还需要进行大规模的临床试验,评估针对肾脏能量消耗代谢不匹配的药物干预对肾脏保护作用的持续时间,以帮助降低青年发病的 T2D 中 DKD 的风险。